Global Project Head, Solid Tumor Immuno-Oncology

Responsibilities:
- Drive worldwide clinical development and life cycle management for a late-stage Solid Tumor Oncology immunotherapeutic compound.
- Lead the Global Product Team (GPT) to ensure optimal global compound development strategy in collaboration with the Global Brand Team (GBT).
- Own compound clinical development strategy and execution, including regulatory-focused studies and budget planning.
- Partner with the Principal Clinical Lead (PCL) and Global Project Manager (GPM) to lead cross-functional GPT execution across translational, regulatory, drug manufacturing, safety, medical, and commercial leads.
- Represent Clinical Development within the GBT for commercial brand strategy; present/discuss development strategy with stakeholders, external investigators/advisory boards, and worldwide regulatory authorities.
- Contribute to Solid Tumor Oncology and cross-asset Disease Area strategies, including clinical development assessment of external BD opportunities in Hematopoietic Stem Cell Transplantation (and implementation if applicable).

Qualifications:
- MD or PhD.
- 7+ years of clinical development experience in Solid Tumor Oncology (biotech/pharma).
- Thorough understanding of global drug development and functional roles.
- Proven leadership of cross-functional clinical development teams.
- Experience with successful marketing authorization submissions.
- Excellent written/verbal communication.
- 20% domestic/international travel.

Preferred:
- Led pivotal trials for regulatory submission in solid tumor oncology.
- Experience preparing regulatory submissions; negotiation/discussion with health authorities.
- Collaboration with commercial/medical in launch and/or post-launch.
- Matrix environment experience; ability to adapt to evolving data/regulatory landscape.

Benefits:
- Health and wellbeing benefits; at least 14 weeks’ gender-neutral parental leave.